JTEHM
IEEE Journal of Translational Engineering in Health and Medicine's unique aim is to publish original work in the intersection of engineering and clinical translation. The journal's focus is interdisciplinary collaborations between researchers, healthcare providers, and industry and aims to publish results and best practices from these translational efforts.
Subscribe
for Updates

Paul C. Pearlman
Paul C. Pearlman (M ‘02) received his M.S., M.Phil., and Ph.D. degrees in electrical engineering from Yale University. He conducted post-doctoral research with the University Medical Center Utrecht. He has been with the U.S. National Cancer Institute’s Center for Global Health since 2013, transitioning to this role on a prestigious AAAS Science and Technology Policy Fellowship. He is currently a Program Director and the Lead for Global Health Technology. Dr. Pearlman is a member of IEEE’s Technical Committee on Translational Engineering for Health Innovations.
Associated articles
JTEHM, Articles, Published Articles
The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring and Treatment in Low- and Middle-Income Countries
Paul C. Pearlman, Rao Divi, Michael Gwede, Pushpa Tandon, Brian S. Sorg, Miguel R. Ossandon, Lokesh Agrawal, Vinay Pai, Houston Baker, Tiffani Bailey Lash
This Article is Featured in the Special Issue NIH-IEEE POCT 2015
Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise,...
Read more
Posted on 12 SEP 2016
JTEHM, Articles, Published Articles
The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low-and Middle-Income Countries: A Review & Commentary
As the burden of non-communicable diseases such as cancer continues to rise in low- and middle-income countries (LMICs), it is essential to identify and invest in promising solutions for cancer control and treatment. Point-of-care technologies (POCTs) have played critical roles...
Read more
Posted on 14 NOV 2017